Table 4 Blood pressure evolution and antihypertensive classes used before and after renal artery revascularization
From: Outcomes after stenting of renal artery stenosis in patients with high-risk clinical features
Pre-procedure | Follow-up contact | p-value | |
|---|---|---|---|
Blood pressure | |||
Systolic BP (mmHg) | 160 (156–180) | 140 (125–150) | 0.007 |
Diastolic BP (mmHg) | 88 (80–100) | 80 (72–90) | 0.078 |
Number of classes of drugs | 4 (4–4.75) | 4 (2.75–4) | 0.138 |
Classes of drugs | n = 12* | n = 12 | |
|---|---|---|---|
ACEi/ARB | 3 (25.0%) | 10 (83.3%) | 0.0112 |
Calcium channel blockers | 10 (83.3%) | 9 (75.0%) | 0.78 |
Beta Blockers | 10 (83.3%) | 10 (83.3%) | 0.84 |
Diuretics | 11 (91.7%) | 3 (25.0%) | 0.002 |
Centrally-acting agents | 10 (83.3%) | 5 (41.7%) | 0.068 |